switching from ozempic to semaglutide What is the recommended approach when (semaglutide) 2mg subcutaneously (SC) weekly Mounjaro (tirzepatide)? Switching from Zepbound to Ozempic

Eligibility criteria for NHS-funded GLP-1 treatment for weight management include: For semaglutide (Wegovy): BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) with at least one weight-related comorbidity For liraglutide (Saxenda): Similar BMI criteria as defined in NICE TA664 Evidence of previous weight management attempts through lifestyle modification Treatment must be initiated within specialist weight management services (Tier 3) Time-limited use as specified in the relevant NICE guidance The referral pathway typically involves: Initial GP consultation: Discuss weight concerns, document BMI and comorbidities, and review previous weight management efforts Tier 2/3 weight management services: Many areas require participation in structured lifestyle programmes before pharmacological intervention Specialist assessment: Referral to specialist weight management services for treatment initiation Ongoing monitoring: Regular review to assess response, tolerability, and continuation criteria Treatment continuation requires achieving the weight loss thresholds specified in the product-specific NICE guidance and SmPCs

By keeping hydrated, you help your body work efficiently to clear out unwanted elements, which is beneficial in the lead-up to a drug test

Whether you're looking to lose weight or simply reset your relationship with food, Tele-Doc is the place to go

The medication decreases food cravings, especially for high-fat, savory items